NCT02472418 - Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 5, 2015

Primary Completion Date

December 1, 2015

Study Completion Date

May 5, 2016

Conditions

Migraine

Interventions

DRUG

DFN-15 Dose A (treatment A)

DFN-15 Dose A administered

DRUG

DFN-15 Dose B (treatment B)

DFN-15 Dose B administered

OTHER

Placebo (treatment C)

Placebo administered

Trial Locations (6)

Michigan Head Pain & Neurological Institute, Ann Arbor

Clinvest/ A Division of Banyan Group, Inc., Springfield

Albuquerque Clinical Trials, Inc., Albuquerque

California Medical Clinic for Headache, Santa Monica

Collaborative Neuroscience Network, LLC, Long Beach

MedVadis Research Corporation, Watertown